Clinical Trial Update: Comparison of a Contemporary Sirolimus-eluting Stent (ihtDEStiny®) With Another Everolimus-eluting Stent (Xience™), Both With Permanent Polymers, in Patients With Acute Coronary Syndrome and de Novo Coronary Artery Lesions [NA]

View source ↗

Summary

This clinical trial compares a sirolimus-eluting stent with a permanent polymer to an everolimus-eluting stent with a permanent polymer in patients with acute c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Coronary Syndrome

Drugs mentioned

• Xience (everolimus-eluting stent with permanent polymer)
• ihtDEStiny (sirolimus-eluting stent with permanent polymer)

Snippet

Sponsor: Fundación EPIC | Conditions: Coronary Artery Disease | NA | Status: RECRUITING